Dephospho Coenzyme A

Identification

总的来说ic Name
Dephospho Coenzyme A
DrugBank Accession Number
DB03170
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 687.554
Monoisotopic: 687.148877955
Chemical Formula
C21H35N7O13P2S
Synonyms
Not Available

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug events
Improve clinical decision support with information oncontraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events & improve clinical decision support.
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Target Actions Organism
UPhosphopantetheine adenylyltransferase Not Available Shigella flexneri
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including:blackbox warnings, adverse reactions, warning & precautions, & incidence rates.
Learn more
Improve decision support & research outcomes with our structured adverse effects data.
Learn more
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRsBrowse all" title="" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
Not Available

Interactions

Drug InteractionsLearn More" title="" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
Not Available

Categories

Drug Categories
Not Available
Chemical TaxonomyProvided byClassyfire
Description
This compound belongs to the class of organic compounds known as purine ribonucleoside diphosphates. These are purine ribobucleotides with diphosphate group linked to the ribose moiety.
Kingdom
Organic compounds
Super Class
Nucleosides, nucleotides, and analogues
Class
Purine nucleotides
Sub Class
Purine ribonucleotides
Direct Parent
Purine ribonucleoside diphosphates
Alternative Parents
Purine ribonucleoside monophosphates/Pentose phosphates/Beta amino acids and derivatives/Glycosylamines/6-aminopurines/Monosaccharide phosphates/Organic pyrophosphates/Aminopyrimidines and derivatives/Monoalkyl phosphates/N-substituted imidazoles
show 14 more
Substituents
6-aminopurine/Alcohol/Alkyl phosphate/Alkylthiol/Amine/Amino acid or derivatives/Aminopyrimidine/Aromatic heteropolycyclic compound/Azacycle/Azole
show 41 more
Molecular Framework
Aromatic heteropolycyclic compounds
External Descriptors
adenosine 5'-phosphate (CHEBI:15468)
Affected organisms
Not Available

Chemical Identifiers

UNII
Not Available
CAS number
Not Available
InChI Key
KDTSHFARGAKYJN-IBOSZNHHSA-N
InChI
InChI=1S/C21H35N7O13P2S/c1-21(2,16(32)19(33)24-4-3-12(29)23-5-6-44)8-39-43(36,37)41-42(34,35)38-7-11-14(30)15(31)20(40-11)28-10-27-13-17(22)25-9-26-18(13)28/h9-11,14-16,20,30-32,44H,3-8H2,1-2H3,(H,23,29)(H,24,33)(H,34,35)(H,36,37)(H2,22,25,26)/t11-,14-,15-,16+,20-/m1/s1
IUPAC Name
{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}({hydroxy[(3R)-3-hydroxy-2,2-dimethyl-3-({2-[(2-sulfanylethyl)carbamoyl]ethyl}carbamoyl)propoxy]phosphoryl}oxy)phosphinic acid
SMILES
CC(C)(COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N1C=NC2=C1N=CN=C2N)[C@@H](O)C(=O)NCCC(=O)NCCS

References

总的来说al References
Not Available
KEGG Compound
C00882
PubChem Compound
444485
PubChem Substance
46504599
ChemSpider
392407
ChEBI
15468
ZINC
ZINC000008551261
PDBe Ligand
COD
PDB Entries
1b6t/2grj/3pxu/3rba/3uf6/5d4e/5o08/5ts2/5zzc/6a6d
show 8 more

Clinical Trials

Clinical TrialsLearn More" title="" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
Not Available
Prices
Not Available
专利
Not Available

Properties

State
Solid
Experimental Properties
Not Available
Predicted Properties
Property Value Source
Water Solubility 2.56 mg/mL ALOGPS
logP -0.98 ALOGPS
logP -5.4 Chemaxon
logS -2.4 ALOGPS
pKa (Strongest Acidic) 1.86 Chemaxon
pKa最强(基本) 4.93 Chemaxon
Physiological Charge -2 Chemaxon
Hydrogen Acceptor Count 14 Chemaxon
Hydrogen Donor Count 9 Chemaxon
Polar Surface Area 300.03 Å2 Chemaxon
Rotatable Bond Count 16 Chemaxon
Refractivity 151.87 m3·mol-1 Chemaxon
Polarizability 63.64 Å3 Chemaxon
Number of Rings 3 Chemaxon
Bioavailability 0 Chemaxon
Rule of Five No Chemaxon
Ghose Filter No Chemaxon
Veber's Rule No Chemaxon
MDDR-like Rule Yes Chemaxon
Predicted ADMET Features
Property Value Probability
Human Intestinal Absorption + 0.8432
Blood Brain Barrier - 0.8272
Caco-2 permeable - 0.7194
P-glycoprotein substrate Substrate 0.733
P-glycoprotein inhibitor I Non-inhibitor 0.6486
P-glycoprotein inhibitor II Non-inhibitor 0.9809
Renal organic cation transporter Non-inhibitor 0.9598
CYP450 2C9 substrate Non-substrate 0.8633
CYP450 2D6 substrate Non-substrate 0.7851
CYP450 3A4 substrate Substrate 0.6004
CYP450 1A2 substrate Non-inhibitor 0.8513
CYP450 2C9 inhibitor Non-inhibitor 0.8424
CYP450 2D6 inhibitor Non-inhibitor 0.8456
CYP450 2C19 inhibitor Non-inhibitor 0.8193
CYP450 3A4 inhibitor Non-inhibitor 0.8125
CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9292
Ames test Non AMES toxic 0.6853
Carcinogenicity Non-carcinogens 0.8304
Biodegradation Not ready biodegradable 1.0
Rat acute toxicity 2.5590 LD50, mol/kg Not applicable
hERG inhibition (predictor I) Weak inhibitor 0.9272
hERG inhibition (predictor II) Non-inhibitor 0.5937
ADMET data is predicted usingadmetSAR, a free tool for evaluating chemical ADMET properties. (23092397)

Spectra

Mass Spec (NIST)
Not Available
Spectra
Spectrum Spectrum Type Splash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-000i-2930102000-19d2796dee5d14788e39
Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-000i-3930000000-d4541feacee9a6c7a4e3
Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-000i-4900000000-1307cbce80b215d981b9
Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-0040-2910618000-58e100b1447a771ecd7c
Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-001i-1910200000-ba57f132dee9798389fa
Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-0a7i-3900000000-d382c7ac6874be7ea151

Targets

Build, predict & validate machine-learning models
Use our structured and evidence-based datasets tounlock new
insights and accelerate drug research.
Learn more
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
Learn more
Kind
Protein
Organism
Shigella flexneri
Pharmacological action
Unknown
总的来说al Function
Pantetheine-phosphate adenylyltransferase activity
Specific Function
Reversibly transfers an adenylyl group from ATP to 4'-phosphopantetheine, yielding dephospho-CoA (dPCoA) and pyrophosphate.
Gene Name
coaD
Uniprot ID
P0A6I8
Uniprot Name
Phosphopantetheine adenylyltransferase
分子量
17836.51 Da
References
  1. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
  2. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]

Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52